Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Scientists have made progress in creating replacement teeth, hair, and glands that work, which could lead to new treatments for missing teeth, baldness, and dryness conditions.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

Minoxidil may help reduce aging effects in brain cells.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Using old drugs for new uses can help treat rare immune deficiencies.

Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

HIV can cause unusual and severe skin problems that are hard to treat.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Targeting CD200 could be a new treatment for rheumatoid arthritis.